Faheem Tahir

Contributing Author

Recent Articles by Faheem Tahir

Dec-11	Strong Momentum in Block (XYZ)'s Square and Cash App Segments Drives UBS' Bullish Stance XYZ Insider Monkey
Dec-11	Nebius Group N.V. (NBIS) Co-Founder Sees Huge AI Demand Ahead Backed by Mega Microsoft, Meta Deals NBIS Insider Monkey
Dec-11	Bullish Analyst Sentiment on Wix.com (WIX) Despite CFRA's Lowered Target and Slower Growth Outlook WIX Insider Monkey
Dec-11	Datadog (DDOG) Sees Bullish Analyst Stance Amid Strong AI and Observability Momentum Despite Recent Stock Pullback DDOG Insider Monkey
Dec-11	Intuit (INTU) Sees Positive Analyst Sentiment Following Strong Fiscal Q1 2026 Results INTU Insider Monkey
Dec-11	ServiceNow (NOW) Deepens Its Long-Term Commitment to Canada with CA$110 Million Investment; Analysts Remain Bullish NOW Insider Monkey
Dec-11	Bullish Analyst Sentiment on Salesforce (CRM) Amid Expanding Enterprise Demand and Strong Q3 Results CRM Insider Monkey
Dec-11	U.S. Approves NVIDIA's (NVDA) H200 Processor Exports to China, CEO Flags China's AI Infrastructure Advantage NVDA Insider Monkey
Dec-11	Bullish Analyst Sentiment on Meta Platforms (META) Amid AI Wearables Acquisition and Next-Generation Hardware Plans META Insider Monkey
Dec-11	Guggenheim Initiates Coverage of Amazon.com (AMZN) with "Buy" Rating and $300 Price Target AMZN Insider Monkey
Dec-11	Arista Networks (ANET) Eyes AI, Data-Center Expansion as Rosenblatt Stays Neutral ANET Insider Monkey
Dec-11	DA Davidson Remains Cautious on Workday (WDAY) Amid Market Saturation and Intensifying Competition WDAY Insider Monkey
Dec-11	Microsoft (MSFT) Announces $23 Billion Investment Plan, Morgan Stanley Reiterates "Buy" Rating MSFT Insider Monkey
Dec-10	Mizuho Securities Reiterates Buy Rating on Adobe (ADBE) Ahead of Q4 Results With $450 PT ADBE Insider Monkey
Dec-10	Bernstein Reiterates "Buy" Rating on Oracle Corporation (ORCL) with $364 PT ORCL Insider Monkey
Dec-01	Strong Analyst Confidence in Compass Therapeutics (CMPX) Driven by CTX-10726 Advancement CMPX Insider Monkey
Nov-30	Strong Operational Performance Steers Analyst Confidence in Nutanix (NTNX) NTNX Insider Monkey
Nov-30	Steady Q3 Growth and Shareholder Returns Reinforce Bentley Systems' (BSY) Outlook BSY Insider Monkey
Nov-30	Strong Analyst Confidence Keeps Via Transportation (VIA) on Track to Capture Its $82 Billion Market VIA Insider Monkey
Nov-30	CAR-Therapy Keeps Analyst Confidence in Arcellx (ACLX) High Ahead of the ASH Meeting ACLX Insider Monkey
Nov-30	Axon Enterprise's (AXON) Acquisition Strategy Drives Bullish Analyst Sentiment Despite Earnings Miss AXON Insider Monkey
Nov-30	Shares Fall, Yet Analysts See Opportunity in Oversold Varonis Systems (VRNS) VRNS Insider Monkey
Nov-30	Strong Operational Momentum and Market Expansions Maintains Bullish Sentiment on e.l.f. Beauty (ELF) ELF Insider Monkey
Nov-30	Strong Base44 Platform Momentum Drives Analyst Confidence in Wix.com (WIX) WIX Insider Monkey
Nov-30	Strong High-Performance AI Cloud Momentum Holds Investor Confidence in CoreWeave (CRWV) CRWV Insider Monkey
Nov-30	Zai Lab (ZLAB) Remains a Buy Amid Strong Commercial and Pipeline Momentum ZLAB Insider Monkey
Nov-30	Strategy's (MSTR) New Credit Rating Dashboard Launch Looks to Calm Investors Amid Crypto November Decline MSTR Insider Monkey
Nov-30	Bullish Analyst Sentiment on Elastic N.V. (ESTC) Holds Despite Softer Net-New Cloud Momentum ESTC Insider Monkey
Nov-29	Analyst Confidence Upbeat on Shattuck Labs (STTK) Amid SL-325 Progress and Earlier Q3 2025 Result STTK Insider Monkey
Nov-29	Analyst Confidence High in Erasca (ERAS) Amid Pipeline Advancement and Earlier Q3 2025 Results ERAS Insider Monkey
Nov-29	Gain Therapeutics' (GANX) Preclinical Momentum Drives Its Progress in Parkinson's Drug Development GANX Insider Monkey
Nov-29	Veritone's (VERI) Debt Discipline and AI Expansion Drive Its Evolving Growth Story VERI Insider Monkey
Nov-29	Analyst Confidence High in Bitfarms Ltd. (BITF) Following Q3 2025 Results BITF Insider Monkey
Nov-29	Analyst Confidence Strong in Annexon (ANNX) Amid Vonaprument Advancement ANNX Insider Monkey
Nov-29	Piper Sandler Initiates Coverage on Opus Genetics, Inc. (IRD) With "Overweight" Rating and $7 PT IRD Insider Monkey
Nov-29	Bullish Outlook on Zura Bio Limited (ZURA) Amid Tibulizumab Phase 2 Clinical Trial Progress ZURA Insider Monkey
Nov-29	H.C. Wainwright Initiates Coverage on Acrivon Therapeutics (ACRV) With "Buy" Rating and $19 PT ACRV Insider Monkey
Nov-29	Analyst Confidence in Orchestra BioMed Holdings (OBIO) High Amid Key Clinical and Strategic Advancements OBIO Insider Monkey
Nov-24	Goldman Sachs Remains Bullish on Devon Energy (DVN) Following Q3 2025 Results DVN Insider Monkey
Nov-24	Piper Sandler Reiterates "Buy" Rating on Expand Energy Corporation (EXE) With $138 PT EXE Insider Monkey
Nov-24	Morgan Stanley Remains Bullish on EQT Corporation (EQT) Following Strong Multi-Year Performance EQT Insider Monkey
Nov-24	Strong EPS Growth to Drive Linde plc (LIN) in 2026, Supports UBS Bullish Stance LIN Insider Monkey
Nov-24	Improved Uranium Pricing Supports Cameco Corporation (CCJ) Through Short-Term Production Headwinds; TD Securities Remains Bullish CCJ Insider Monkey
Nov-24	UBS Remains Bullish on ConocoPhillips (COP) Amid Cost Pressures and Softer 2026 Oil Volume Outlook COP Insider Monkey
Nov-24	Susquehanna Remains Bullish on Occidental Petroleum (OXY) Amid Strong Earnings and Production Momentum OXY Insider Monkey
Nov-24	Montney Expansion and NuVista Energy Acquisition to Support Ovintiv (OVV) Future Growth; Citi Remains Bullish OVV Insider Monkey
Nov-24	Goldman Sachs Remains Bullish on The Mosaic Company (MOS) Following Q3 2025 Results MOS Insider Monkey
Nov-24	Strong Cash Flow to Support EOG Resources' (EOG) Robust Pipeline Amid Oil Supply Headwinds; RBC Capital Remains Bullish EOG Insider Monkey
Nov-24	Evercore ISI Remains Bullish on Air Products and Chemicals (APD) Following Q4 2025 Results APD Insider Monkey
Nov-24	Piper Sandler Reduces PT on Range Resources Corporation (RRC) to $37 Following Q3 2025 Results RRC Insider Monkey
Nov-21	Hut 8 (HUT) Sells Its 310-Megawatt Portfolio of Four Natural Gas Plants HUT Insider Monkey
Nov-21	Canaccord Genuity Remains Bullish on IREN Limited (IREN) Following Q3 2025 Results IREN Insider Monkey
Nov-21	Mizuho Remains Bullish on Strategy (MSTR) Following Q3 2025 Results MSTR Insider Monkey
Nov-21	SoFi Technologies' (SOFI) SoFi Crypto Launch Makes It First Nationally Chartered, FDIC-Insured Bank in the U.S. SOFI Insider Monkey
Nov-21	William Blair's Jeffrey Reiterates "Buy" Rating on Block (XYZ) Following Q3 2025 Results XYZ Insider Monkey
Nov-21	Citizens Remains Bullish on Robinhood Markets (HOOD) Amid Leadership Changes HOOD Insider Monkey
Nov-21	Bernstein's Chhugani Remains Bullish on Coinbase Global (COIN) with $510 PT COIN Insider Monkey
Nov-17	Evercore Remains Bullish on Allegro MicroSystems (ALGM), Cites Robust Automotive and Data Center Cycles ALGM Insider Monkey
Nov-17	Riley Reduces Its Price Target on Bitdeer Technologies (BTDR) to $29, Maintains "Buy" Rating BTDR Insider Monkey
Nov-17	Goldman Sachs Maintains Neutral Stance on Alkami Technology (ALKT) Following Q3 2025 Results ALKT Insider Monkey
Nov-17	Goldman Sachs Remains Bullish on Vertex (VERX) After Q3 2025 Results VERX Insider Monkey
Nov-17	Synaptics (SYNA) Partners with Qualcomm to Advance Next-Generation Touch and Fingerprint Sensor Technologies SYNA Insider Monkey
Nov-17	Robert W. Baird Maintains "Buy" Rating on Commvault Systems (CVLT) With $215 PT CVLT Insider Monkey
Nov-17	BofA Remains Bullish on OneStream (OS), Cites Sustained Demand for Its AI-Powered Finance Solutions OS Insider Monkey
Nov-17	DA Davidson Raises PT on Q2 Holdings (QTWO) to $82, Maintains "Neutral" Rating QTWO Insider Monkey
Nov-17	Citi Maintains "Buy" Rating on Pagaya Technologies (PGY) With $40 PT PGY Insider Monkey
Nov-17	Barclays Sees "Potentially Huge Opportunity" for Impinj (PI), Cites Growing Momentum in Grocery Deployments PI Insider Monkey
Nov-16	RBC Capital Remains Bullish on Viridian Therapeutics (VRDN) Following Q3 2025 Results VRDN Insider Monkey
Nov-16	UroGen Pharma (URGN) Closes Q3 2025 With $127.4 Million in Cash Amid Rising R&D Costs URGN Insider Monkey
Nov-16	Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA's 75% Growth in U.S. Prostacyclin Revenue LQDA Insider Monkey
Nov-16	Edgewise Therapeutics (EWTX) Reports Heightened R&D Activity in Q3 2025 EWTX Insider Monkey
Nov-16	BMO Capital Remains Bullish on Structure Therapeutics (GPCR), Cites Upcoming Trial Readouts GPCR Insider Monkey
Nov-16	H.C. Wainwright Maintains Its Bullish Stance on Vera Therapeutics (VERA), Sees Strong Future Revenue Growth VERA Insider Monkey
Nov-16	Jones Trading Remains Bullish on Janux Therapeutics (JANX) Amid Promising Developments in Prostate Cancer Program JANX Insider Monkey
Nov-16	Jefferies Maintains "Buy" Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning WVE Insider Monkey
Nov-16	William Blair Maintains Bullish Stance on Biohaven (BHVN), Sees Robust Operational Growth BHVN Insider Monkey
Nov-16	JPMorgan Reduces PT on Syndax Pharmaceuticals (SNDX) to $33, Maintains "Overweight" Rating SNDX Insider Monkey
Nov-15	Microsoft Corporation (MSFT) Unveils Its $10 Billion Investment Plan for AI Infrastructure in a Data Center in Portugal MSFT Insider Monkey
Nov-15	Advanced Micro Devices (AMD) Gains Investor Momentum, Mizuho Raises PT to $285 AMD Insider Monkey
Nov-15	Amazon.com (AMZN) Looks to Expand Its Amazon Bazaar to 14 New Markets AMZN Insider Monkey
Nov-15	TD Cowen Maintains "Buy" on Alphabet (GOOG), Cites Company's Strong Growth Trajectory GOOG Insider Monkey
Nov-15	Citi Maintains "Buy" Rating on Broadcom (AVGO) with $415 PT AVGO Insider Monkey
Nov-15	Northland Capital Reduces PT on Nebius Group N.V. (NBIS) to $206, Maintains "Outperform" Rating NBIS Insider Monkey
Nov-15	Loop Capital Raises PT on Arm Holdings (ARM) to $180 Following Q2 Results ARM Insider Monkey
Nov-10	DuPont de Nemours (DD) Announces Q3 2025 Results; KeyBanc's Yefremov Raises PT to $45 DD Insider Monkey
Nov-10	SM Energy Company (SM) Reports Q3 2025 Results, Reports 26% YoY Production Growth SM Insider Monkey
Nov-10	H.C. Wainwright Reiterates "Buy" Rating on Denali Therapeutics (DNLI) With $32 PT Following Q3 Results DNLI Insider Monkey
Nov-10	Aurora Innovation (AUR) Closes Q3 2025 With $1.6 Billion in Liquidity AUR Insider Monkey
Nov-10	William Blair Reiterates "Buy" Rating on Viking Therapeutics (VKTX) Following New VK2735 Data VKTX Insider Monkey
Nov-10	Summit Therapeutics (SMMT) Reports Positive Results from the Phase III HARMONi Trial SMMT Insider Monkey
Nov-10	Morgan Stanley Reaffirms "Buy" Rating on Ultragenyx Pharmaceutical (RARE) with $55 PT RARE Insider Monkey
Nov-10	TD Cowen Reiterates "Buy" Rating on Vaxcyte (PCVX) With $50 PT PCVX Insider Monkey
Nov-10	H.C. Wainwright Remains Bullish on Legend Biotech (LEGN), Cites Solid Growth Trajectory for CARVYKTI Therapy LEGN Insider Monkey
Nov-10	Canaccord Genuity Remains Bullish on Strategy (MSTR), Cites Bitcoin Yield Strategy as Key Growth Driver MSTR Insider Monkey
Nov-10	Goldman Sachs Bullish on Amicus Therapeutics (FOLD) Following Q3 2025 Results FOLD Insider Monkey
Nov-10	RBC Capital Raises PT on Ocular Therapeutix (OCUL) to $24 Amid Solid Growth Trajectory OCUL Insider Monkey
Nov-10	Clear Street Raises PT on Beam Therapeutics (BEAM) to $37 Following Q3 Results BEAM Insider Monkey
Nov-10	QXO (QXO) Reports Q3 2025 Results, Wells Fargo Reiterates Bullish Stance QXO Insider Monkey
Nov-10	Chime Financial (CHYM) Surpasses Its Guidance for Q3 2025, Reports 29% YoY Revenue Growth CHYM Insider Monkey
Nov-10	RBC Capital Remains Bullish on Bread Financial Holdings (BFH) Amid Stable Outlook BFH Insider Monkey

Faheem Tahir

Recent Articles by Faheem Tahir

Upgrade your FINVIZ experience